Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus

Kidney International

Volumn 59, Issue 4, 2001, Pages 1432-1438

  Lansang, M Cecilia ^a   Price, Deborah A ^a   Laffel, Lori M B ^a   Osei, Suzette Y ^a   Fisher, Naomi D L ^a   Erani, David ^a   Hollenberg, Norman K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ACE inhibition; AT1 receptor blocker; Hemodynamics; Renal plasma flow; Renin angiotensin system; Vascular tone

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; KININ; NITRIC OXIDE; PROSTAGLANDIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY CLEARANCE; MALE; MICROALBUMINURIA; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; SODIUM BALANCE; VASODILATATION;

EID: 0035066968     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.0590041432.x     Document Type: Article

References (42)

1. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy
2. Predicting diabetic nephropathy in insulin dependent patients
3. Increased glomerular filtration rate as a predictor of diabetic nephropathy: An 8-year prospective study
4. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies
5. Glomerular hemodynamics in experimental insulin-dependent diabetes mellitus
6. Pathogenesis of diabetic glomerulopathy: Hemodynamic considerations
7. Short and long term effects of antihypertensive therapy in the diabetic rat
8. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy
9. Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension
10. Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes
11. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass
12. Effect of captopril on renal hemodynamics in the treatment of resistant renal hypertension
13. Short-term effect of angiotensin-converting-enzyme inhibitor enalapril in incipient diabetic nephropathy
14. Comparison of the renal effects of angiotensin-converting-enzyme inhibitor and Ca antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: A randomized controlled trial
15. Captopril in the treatment of hypertension in type 1 and type 2 diabetic patients
16. Enalapril does not alter renal function in normotensive, normoalbuminuric, hyperfiltering type 1 (insulin-dependent) diabetic children
17. Captopril acutely lowers albuminuria in normotensive patients with diabetic nephropathy
18. Acute and long-term renal effects of angiotensin-converting-enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients
19. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria
20. Blood glucose control determines the renal hemodynamic response to angiotensin-converting-enzyme inhibition in type 1 diabetes
21. Renal abnormalities in normotensive insulin-dependent diabetic offspring of hypertensive parents
22. Endothelin-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries
23. Report on the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
24. Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma
25. The simultaneous measurement of aldosterone, cortisol, and corticosterone in human peripheral plasma by displacement analysis
26. Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans
27. Effect of the angiotensin II antagonist, eprosartan, on hyperglycemia-induced activation of intrarenal renin-angiotensin system in healthy humans
28. Renal vascular response to interruption of the renin-angiotensin system in normal man
29. Pathways for angiotensin II generation in intact human tissue: Evidence from comparative pharmacological interruption of the renin system
30. Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects
31. Renal hemodynamic and hormonal response to the angiotensin II antagonist, candesartan
32. ACE inhibition and the kidney: Species variation in the mechanisms responsible for the renal hemodynamic response
33. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?
34. Responses to converting enzyme and renin inhibition: Role of angiotensin II in humans
35. Effect of hyperglycemia on arterial pressure, plasma renin activity, and renal function in early diabetes
36. Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus
37. The paradox of the low-renin state in diabetic nephropathy
38. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes
39. Control of the renal renin system by local factors
40. Changes in blood pressure, body fluids, circulating angiotensin II, and aldosterone with improved diabetic control
41. Control of renal hemodynamics in hyperglycemia: Possible role of tubuloglomerular feedback
42. Autonomy of the renin system in type II diabetes mellitus: Dietary sodium and renal hemodynamic responses to ACE inhibition